NDC 0781-7088-33 - Mesalamine

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0781-7088
Requested NDC
0781-7088-33
Package NDCs from labels
0781-7088-33, 0781-7088-06
Manufacturer
Sandoz Inc
Effective date
2021-12-01
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Mesalamine - Sandoz IncSandoz Inc2021-12-01HUMAN PRESCRIPTION DRUG LABEL

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0781-7088-06EA - Each0781-7088edd42142-1cb4-45ea-b31b-89a951f1939b12020-02-13
0781-7088-33EA - Each0781-70882f809875-3051-4d24-843a-02974add196712019-12-10

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 59 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MesalamineMESALAMINEIngenus Pharmaceuticals, LLC58503afe-b8d4-4710-a194-e3acd64ecf1f2026-11-05Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MESALAMINEMESALAMINEKLM Laboratories Private Limited54cfed92-5e28-4a4d-a70f-2a60b5b54c122026-11-03Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINEAurobindo Pharma Limitedd6c0fc76-644e-4301-9672-f432061e3d372026-11-02Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
mesalamineMESALAMINEZydus Pharmaceuticals USA Inc.533bfaf5-0add-4b49-a4f2-ddea2b83f65d2026-10-27Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
LialdaMESALAMINETakeda Pharmaceuticals America, Inc.3098a080-be86-4265-9818-7fc4beab77b72026-10-26Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINETakeda Pharmaceuticals America, Inc.4e3b6325-a5bf-4c47-931c-142c0e4d7c3a2026-10-23Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
PentasaMESALAMINETakeda Pharmaceuticals America, Inc.e39d9a3d-5d3a-4bb6-aab1-fdbb2a5986062026-10-23Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
APRISOMESALAMINESalix Pharmaceuticals, Inc.7951139c-b271-45a4-b523-34b23800917b2026-10-22Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINEZydus Pharmaceuticals USA Inc.cd8493f7-91fd-4c2d-b3d7-c1301825586b2026-10-22Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINEAscend Laboratories, LLC43f69db3-81ac-4da4-a61f-fbba6299d9c22026-10-19Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
CanasaMESALAMINEAllergan, Inc.89d91601-152b-4398-bebe-af1c023e99352026-10-14Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINETeva Pharmaceuticals, Inc.e3b84397-a5a5-40cf-8145-0584103d465f2026-09-22Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINETeva Pharmaceuticals USA, Inc.6fd0a906-e1b5-4238-a79b-a195510ddc842026-09-21Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINEAmerican Health Packagingc1ed6fcc-7fd4-4b8a-9ddb-e772ea930e9e2026-09-17Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
mesalamineMESALAMINEZydus Pharmaceuticals USA Inc.ad8c7930-92e2-4372-a874-da22b9ae333e2026-09-17Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINEAmneal Pharmaceuticals LLC00f77203-3615-47e8-ae25-6e1cf8a2a00a2026-09-16Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
RowasaMESALAMINEViatris Specialty LLCe505ab99-1943-4216-a178-4d5dbe64e3b22026-08-03Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
mesalamineMESALAMINEMajor Pharmaceuticals14ac4435-903b-41f5-a3c4-8c73de3e4cef2026-07-27Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINESandoz Inc47b5d1ee-b439-4ccb-9b01-c0875ccd748a2026-06-30Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC
MesalamineMESALAMINENuvaila Limited875d573f-99a1-426a-8321-4d511690d5032026-06-03Warnings, Adverse reactionsExact identifier
unii: 4Q81I59GXC

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.